CAS Medical Systems Expands Board

Branford, Conn.-based CAS Medical Systems Inc. (CASMED) has added Alan W. Milinazzo to its board of directors. Milinazzo’s election became effective as of June 23 following the company’s annual meeting of stockholders, and increased the size of CASMED’s board to seven directors. Milinazzo will serve on the compensation committee.

Milinazzo is president and CEO of InspireMD Inc., an interventional device company focused on developing novel embolic protection products, where he has served since 2013. He is also on InspireMD’s board. Prior to InspireMD he was CEO of Orthofix International N.V., an orthopedic company. Milinazzo previously held executive positions at Medtronic Inc., Aspect Medical Systems, Inc. and Boston Scientific Corporation.

Milinazzo also serves on the boards of the Musculoskeletal Transplant Foundation and Flexion Therapeutics Inc. He formerly served on the boards of Orthofix International, N.V., Medpace Inc., and HET Systems. He holds a bachelor’s degree from Boston College.

“Alan’s experience as a senior executive and board member provides CASMED with another key resource as we continue to develop a high-growth, profitable and global healthcare businesses,” said Thomas M. Patton, president and CEO of CASMED. “We welcome Alan to our board. With more than 25 years of experience in the management and marketing of medical devices, along with expertise in the cardiovascular and patient monitoring fields, Alan brings valuable context and insights to commercial strategies and operational issues.”

CASMED makes medical devices for non-invasive patient monitoring.